Skip to main content
Fig. 4 | BMC Nephrology

Fig. 4

From: A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-Alfa) vs. Eprex® in patients with anaemia of chronic renal failure

Fig. 4

Hemoglobin levels (mean ± SD) and epoetin dosage during the study period The line graphs depict the average haemoglobin levels (top) and the epoetin dosage (bottom) of subjects during the maintenance and open label phases. The error bars refer to the standard deviation (SD)

Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us